JAN 24, 2017 2:05 PM PST

One-Third of Asthma Patients are Misdiagnosed

WRITTEN BY: Xuan Pham

About one in 12 Americans, or 25 million people, are diagnosed with asthma. But a new study reports that about a third of those people are misdiagnosed, and may be taking asthma medication unnecessarily.

Asthma is a chronic respiratory condition marked difficulty breathing, coughing, wheezing, and shortness of breath. These symptoms are brought on by the airway swelling up and producing extra mucus in response to different types of allergens. Patients diagnosed with asthma take long-term medications like inhaled corticosteroids, and may also have to carry fast-acting rescue medications in case of a serious asthma attack.

However, recent studies suggest that not all patients diagnosed with asthma actually have asthma. The current study expanded on this by studying over 600 patients diagnosed with asthma in the past five years in Canada. To confirm whether the patients truly have asthma, the scientists used a series of tests including at home peak flow meter, spirometry, and serial bronical challenge tests.

They found that a third of the patients diagnosed with asthma did not, in fact, have active asthma.

"It's impossible to say how many of these patients were originally misdiagnosed with asthma, and how many have asthma that is no longer active," said Dr. Shawn Aaron, senior scientist and respirologist at The Ottawa Hospital and professor at the University of Ottawa, and the study’s senior author.

"What we do know is that they were all able to stop taking medication that they didn't need - medication that is expensive and can have side effects." Aaron and his team reported that 90 percent of the patients reclassified as not having asthma were able to stop taking their asthma medication without adverse effects.

The team also found that many patients had already suspected a misdiagnosis all along. "It wasn't a surprise to most patients when we told them they didn't have asthma," said Dr. Aaron. "Some knew all along that their puffer wasn't working, while others were concerned that they might have something more serious. Thankfully, the majority of the conditions were mild and easily treated."

In the 33 percent of patients that didn’t seem to have asthma, Aaron’s team found that the majority didn’t actually have anything medically wrong. In some, the problem seemed minor, like allergies or heartburn.

So why does asthma have such a high instance of overdiagnosis? In looking through the records of how patients were diagnosed, Aaron’s team discovered something else alarming. It seems 49 percent of patients were diagnosed without evidence from airflow tests required by medical guidelines. Doctors seemed to rely more on the patient’s chief complaints and their own observations.

"Doctors wouldn't diagnose diabetes without checking blood sugar levels, or a broken bone without ordering an x-ray," said Dr. Aaron. "But for some reason many doctors are not ordering the spirometry tests that can definitely diagnose asthma."

"We need to educate physicians and the public to get the diagnosis right in the first place," said Dr. Aaron. "Patients who have difficulty breathing should ask their doctor to order a breathing test (spirometry) to determine if they might have asthma or even Chronic Obstructive Pulmonary Disease (COPD). Similarly, if patients think they may have been misdiagnosed with asthma or that they no longer have asthma, they should ask their doctor for a spirometry test. Asthma can be deadly, so patients should never go off their medication without speaking to a doctor first."

Additional sources: MNT, Ottowa Hospital Research Institute

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 22, 2020
Drug Discovery & Development
Only 3% of COVID-19 Antibody Tests Approved by FDA
APR 22, 2020
Only 3% of COVID-19 Antibody Tests Approved by FDA
So far, only 3% of at least 90 COVID-19 antibody tests in the US have been approved by the Food and Drug Administration ...
MAY 20, 2020
Clinical & Molecular DX
QMS Competencies Your Reagent Supplier Should Possess
MAY 20, 2020
QMS Competencies Your Reagent Supplier Should Possess
The ability of a clinical laboratory to provide consistent and reliable results to their customers depends on the consis ...
JUL 09, 2020
Clinical & Molecular DX
Women's Hair Holds Fertility Clues
JUL 09, 2020
Women's Hair Holds Fertility Clues
A new predictive tool for measuring women’s fertility uses an unlikely biological source for answers: hair. During ...
JUL 28, 2020
Clinical & Molecular DX
Cancer Diagnostics Go Skin Deep
JUL 28, 2020
Cancer Diagnostics Go Skin Deep
The average adult human has between 16 and 22 square feet of skin. This multifaceted organ serves a multitude of functio ...
JUL 27, 2020
Clinical & Molecular DX
Guidance for Optimization of a Real-Time qPCR Assay
JUL 27, 2020
Guidance for Optimization of a Real-Time qPCR Assay
Optimizing the formulation of reagents for your qPCR assay requires careful experimental design that looks across severa ...
AUG 01, 2020
Cardiology
Identifying Biomarkers for the Diagnosis of Diabetic Cardiomyopathy
AUG 01, 2020
Identifying Biomarkers for the Diagnosis of Diabetic Cardiomyopathy
Type 2 diabetes affects millions around the world.  By itself, it prevents your body from properly using sugars fro ...
Loading Comments...